Download PDF
Horm Metab Res 2012; 44(11): 825-831
DOI: 10.1055/s-0032-1316332
Original Basic
© Georg Thieme Verlag KG Stuttgart · New York

PKC Activation is Required for TSH-mediated Lipolysis via Perilipin Activation

A. B. Thrush
1   Chronic Disease Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
2   Departments of Medicine and of Biochemistry, Microbiology & Immunology, University of Ottawa, Ottawa, Ontario, Canada
,
A. Gagnon
1   Chronic Disease Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
2   Departments of Medicine and of Biochemistry, Microbiology & Immunology, University of Ottawa, Ottawa, Ontario, Canada
,
A. Sorisky
1   Chronic Disease Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
2   Departments of Medicine and of Biochemistry, Microbiology & Immunology, University of Ottawa, Ottawa, Ontario, Canada
› Author Affiliations
Further Information

Publication History

received 05 January 2012

accepted 01 June 2012

Publication Date:
22 June 2012 (online)

Also available at
    Permissions and Reprints

Abstract

Adipocytes express TSH receptors, and TSH can stimulate cAMP-dependent protein kinase, perilipin phosphorylation, and lipolysis in human and mouse 3T3-L1 adipocytes. TSH activates PKC in thyrocytes. Since PKC has been implicated in lipolysis in adipocytes, we examined whether the family of conventional isoforms of PKC (cPKC) is a target of TSH in adipocytes, and whether cPKC is required for TSH-stimulated lipolysis. Differentiated 3T3-L1 and subcutaneous abdominal human adipocytes in culture were treated with TSH in the presence or absence of either PKC inhibitor Gö6976 (inhibits PKCα, βI) or Gö6983 (inhibits PKCα, βI, βII, γ, δ). Activation of cPKC was assessed by phospho-(ser) PKC substrate antibody immunoblot analysis. Perilipin phosphorylation was measured by SDS-PAGE electromobility shift followed by anti-perilipin immunoblot analysis. Lipolysis was quantified by the amount of nonesterified fatty acids (NEFAs) released into the medium. TSH strongly and significantly activated cPKC in differentiated human and 3T3-L1 adipocytes from undetectable levels in control conditions. This cPKC stimulation in human adipocytes by TSH was reduced significantly by 40% or 48% in the presence of PKC inhibitor Gö6983 or Gö6976, respectively. Gö6976 inhibited TSH-stimulated human adipocyte perilipin phosphorylation and NEFA release by 80% and 50%, respectively. We conclude that cPKC is activated by TSH in human differentiated adipocytes. Based on the effects of cPKC inhibition, cPKC activation is required for TSH-stimulated perilipin phosphorylation and lipolysis in human differentiated adipocytes.

Key words

nonesterified fatty acids - subclinical hypothyroidism - 3T3-L1
 

  • References

  • 1 Latif R, Morshed SA, Zaidi M, Davies TF. The thyroid-stimulating hormone receptor: impact of thyroid-stimulating hormone and thyroid-stimulating hormone receptor antibodies on multimerization, cleavage, and signaling. Endocrinol Metab Clin North Am 2009; 38: 319-341
    CrossrefPubMedGoogle Scholar
  • 2 Rivas M, Santisteban P. TSH-activated signaling pathways in thyroid tumorigenesis. Mol Cell Endocrinol 2003; 213: 31-45
    CrossrefPubMedGoogle Scholar
  • 3 Morshed SA, Latif R, Davies TF. Characterization of thyrotropin receptor antibody-induced signaling cascades. Endocrinology 2009; 150: 519-529
    Google Scholar
  • 4 Morshed SA, Ando T, Latif R, Davies TF. Neutral antibodies to the TSH receptor are present in Graves’ disease and regulate selective signaling cascades. Endocrinology 2010; 151: 5537-5549
    Google Scholar
  • 5 Endo T, Ohta K, Haraguchi K, Onaya T. Cloning and functional expression of a thyrotropin receptor cDNA from rat fat cells. J Biol Chem 1995; 270: 10833-10837
    CrossrefPubMedGoogle Scholar
  • 6 Janson A, Rawet H, Perbeck L, Marcus C. Presence of thyrotropin receptor in infant adipocytes. Pediatr Res 1998; 43: 555-558
    CrossrefPubMedGoogle Scholar
  • 7 Sorisky A, Bell A, Gagnon A. TSH receptor in adipose cells. Horm Metab Res 2000; 32: 468-474
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Bell A, Gagnon A, Grunder L, Parikh SJ, Smith TJ, Sorisky A. Functional TSHR receptor in human abdominal preadipocytes and orbital fibroblasts. Am J Physiol: Cell Physiol 2000; 279: C335-C340
    PubMedGoogle Scholar
  • 9 Nannipieri M, Cecchetti F, Anselmino M, Camastra S, Niccolini P, Lamacchia M, Rossi M, Iervasi G, Ferrannini E. Expression of thyrotropin and thyroid hormone receptors in adipose tissue of patients with morbid obesity and/or type 2 diabetes: effects of weight loss. Int J Obes 2009; 33: 1001-1006
    CrossrefPubMedGoogle Scholar
  • 10 Shintani M, Nishimura H, Akamizu T, Yonemitsu S, Masuzaki H, Ogawa Y, Hosoda K, Inoue G, Yoshimasa Y, Nakao K. Thyrotropin decreases leptin production in rat adipocytes. Metabolism 1999; 48: 1570-1574
    CrossrefPubMedGoogle Scholar
  • 11 Antunes TT, Gagnon A, Langille ML, Sorisky A. Thyroid-stimulating hormone induces interleukin-6 release from human adipocytes through activation of the nuclear factor-κB pathway. Endocrinology 2008; 149: 3062-3066
    CrossrefPubMedGoogle Scholar
  • 12 Marcus C, Ehrén H, Bolme P, Arner P. Regulation of lipolysis during the neonatal period. Importance of thyrotropin. J Clin Invest 1988; 82: 1793-1797
    CrossrefPubMedGoogle Scholar
  • 13 Gagnon A, Antunes TT, Ly T, Pongsuwan P, Gavin C, Lochnan HA, Sorisky A. TSH-stimulates lipolysis in adipocytes in culture and raises serum free fatty acid levels in vivo. Metabolism 2010; 59: 547-553
    CrossrefPubMedGoogle Scholar
  • 14 Elgadi A, Zemack H, Marcus C, Norgren S. Tissue-specific knockout of TSHr in white adipose tissue increases adipocyte size and decreases TSH-induced lipolysis. Biochem Biophys Res Commun 2010; 393: 526-530
    CrossrefPubMedGoogle Scholar
  • 15 Dardano A, Ghiadoni L, Plantinga Y, Caraccio N, Bemi A, Duranti E, Taddei S, Ferrannini E, Salvetti A, Monzani F. Recombinant human TSH reduces endothelium-dependent vasodilation in patients monitored for differentiated thyroid carcinoma. J Clin Endocrinol Metab 2006; 91: 4175-4178
    CrossrefPubMedGoogle Scholar
  • 16 Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr Rev 2008; 29: 76-131
    CrossrefPubMedGoogle Scholar
  • 17 Caraccio N, Natali A, Sironi A, Baldi S, Frascerra S, Dardano A, Monzani F, Ferrannini E. Muscle metabolism and exercise tolerance in subclinical hypothyroidism: a controlled trial of levothyroxine. J Clin Endocrinol Metab 2005; 90: 4057-4062
    CrossrefPubMedGoogle Scholar
  • 18 Andersson DP, Lofgren P, Thorell A, Arner P, Hoffstedt J. Visceral fat cell lipolysis and cardiovascular risk factors in obesity. Horm Metab Res 2011; 43: 809-815
    Article in Thieme ConnectPubMedGoogle Scholar
  • 19 Rodondi N, den Elzen WP, Bauer DC, Cappola AR, Razvi S, Walsh JP, Asvold BO, Iervasi G, Imaizumi M, Collet TH, Bremner A, Maisonneuve P, Sgarbi JA, Khaw KT, Vanderpump MP, Newman AB, Comuz J, Franklyn JA, Westendorp RG, Vittinghoff E, Gussekoo J. Thyroid Studies Coolaboration. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA 2010; 304: 1365-1374
    CrossrefPubMedGoogle Scholar
  • 20 Antunes TT, Gagnon A, Chen B, Pacini F, Smith TJ, Sorisky A. Interleukin-6 release from human abdominal adipose cells is regulated by thyroid-stimulating hormone: effect of adipocyte differentiation and anatomic depot. Am J Physiol Endocrinol Metab 2006; 290: E1140-E1144
    CrossrefPubMedGoogle Scholar
  • 21 Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685
    CrossrefPubMedGoogle Scholar
  • 22 Constant VA, Gagnon A, Landry A, Sorisky A. Macrophage-conditioned medium inhibits the differentiation of 3T3-L1 and human abdominal preadipocytes. Diabetologia 2006; 49: 1402-1411
    CrossrefPubMedGoogle Scholar
  • 23 Tansey JT, Sztalryd C, Hlavin EM, Kimmel AR, Londos C. The central role of perilipin A in lipid metabolism and adipocyte lipolysis. IUBMB Life 2004; 56: 379-385
    CrossrefPubMedGoogle Scholar
  • 24 Birnbaumer L, Rodbell M. Adenyl cyclase in fat cells. II. Hormone receptors. J Biol Chem 1969; 244: 3477-3482
    PubMedGoogle Scholar
  • 25 Idris I, Gray S, Donnelly R. Protein kinase C activation: isozyme-specific effects on metabolism and cardiovascular complications in diabetes. Diabetologia 2001; 44: 659-673
    CrossrefPubMedGoogle Scholar
  • 26 Lim JY, Kim WH, Park SI. Go6976 prevents TNF-α-induced suppression of adiponectin expression in 3T3-L1 adipocytes: putative involvement of protein kinase C. FEBS. Lett 2008; 582: 3473-3478
    PubMedGoogle Scholar
  • 27 Fricke K, Heitland A, Maronde E. Cooperative activation of lipolysis by protein kinase A and protein kinase C pathways in 3T3-L1 adipocytes. Endocrinology 2004; 145: 4940-4947
    CrossrefPubMedGoogle Scholar
  • 28 Sánchez-Margalet V, González-Yanes C, Najib S, Santos-Alvarez J. Metabolic effects and mechanism of action of the chromogranin A-derived peptide pancreastatin. Regul Pept 2010; 161: 8-14
    CrossrefPubMedGoogle Scholar
  • 29 McDonough PM, Agustin RM, Ingermanson RS, Loy PA, Buehrer BM, Nicoll JB, Prigozhina NL, Mikic I, Price JH. Quantification of lipid droplets and associated proteins in cellular models of obesity via high-content/high-throughput microscopy and automated image analysis. Assay Drug Dev Technol 2009; 7: 440-460
    CrossrefPubMedGoogle Scholar
  • 30 de Mazancourt P, Darimont C, Giot J, Giudicelli Y. Differential modulation of the adenylate cyclase/cyclic AMP stimulatory pathway by protein kinase C activation in rat adipose tissue and isolated fat cells. Influence of collagenase digestion. Biochem Pharmacol 1991; 42: 1791-1797
    CrossrefPubMedGoogle Scholar
  • 31 Matsumoto S, Yoshida S, Ikeda M, Saiki C, Takeda M. Effects of PKC and PHA inhibitors on the cAMP-stimulant-induced enhancement of tetrodotoxin-resistant Na+ (Nav1.8) currents. Open Pharmacol J 2008; 2: 17-19
    PubMedGoogle Scholar
  • 32 Zhai W, Xu C, Ling Y, Liu S, Deng J, Londos C, Xu G. Increased lipolysis in adipose tissues is associated with elevation of systemic free fatty acids and insulin resistance in perilipin null mice. Horm Metab Res 2010; 42: 247-253
    Article in Thieme ConnectPubMedGoogle Scholar
  • 33 Gorin E, Tai LR, Honeyman TW, Goodman HM. Evidence for a role of protein kinase C in the stimulation of lipolysis by growth hormone and isoproterenol. Endocrinology 1990; 126: 2973-2982
    CrossrefPubMedGoogle Scholar
  • 34 Nakamura J. Protein kinase C attenuates β-adrenergic receptor-mediated lipolysis, probably through inhibition of the beta1-adrenergic receptor system. Arch Biochem Biophys 2006; 447: 1-10
    CrossrefPubMedGoogle Scholar